Shoshana Rosenzweig

Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital

Papers

5

Total Citations

53

H-Index

4

About

Dr. Shoshana Rosenzweig is a urologic surgeon and researcher whose work focuses on improving surgical outcomes for patients with bladder and kidney cancers, with a particular emphasis on perioperative care and renal function preservation. Her major contributions include pioneering research on the impact of anesthetic choice on bladder cancer recurrence, where her 2020 study comparing total intravenous versus volatile anesthesia during robot-assisted radical cystectomy (23 citations) has sparked important clinical discussions. She has also advanced postoperative recovery by implementing nonopioid protocols following complex robotic surgeries (16 citations), addressing the critical need for pain management alternatives. Dr. Rosenzweig’s work demonstrates that neobladder creation is a viable option even for patients with chronic kidney disease (7 citations), challenging previous surgical limitations. Her comparative analyses of open versus minimally-invasive partial nephrectomy for renal cell carcinoma (4 citations) provide valuable oncological outcome data, while her investigation into preoperative kidney function as a predictor of post-cystectomy renal decline (3 citations) offers practical guidance for postoperative management. Through these studies, Dr. Rosenzweig has established herself as a thoughtful contributor to evidence-based urologic oncology, bridging surgical technique with patient-centered outcomes.

Research Focus

Key Achievements

4
H-Index
5
Papers
53
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis
23 citations · 2020
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago